Utilization of authorization within Skanditek to repurchase own shares The Annual General Meeting on March 26, 2007, of Skanditek Industriförvaltning AB (publ) approved the proposal to authorize the Board of Directors to purchase the company's own shares for the purpose to enable the Board to adapt the capital structure.The company's Board has now decided to utilize this authorization. The shares will be purchased on the Stockholm Stock Exchange (Stockholmsbörsen) at a price within the registered share price interval on each occasion when the Board finds it favourable for the company's shareholders. Purchase can be made as of December 5, 2007, until next year's Annual General Meeting on April 7, 2008. No acquisitions are intended to be made during a 30-day period prior to the announcement of quarterly result, the day of announcement included. The total number of outstanding shares in Skanditek is 65,505,080 and the maximum number of shares which can be repurchased is 6,550,508. Stockholm, December 4, 2007 SKANDITEK INDUSTRIFÖRVALTNING AB (publ) Skanditek is an industrial holding company owning stock in Swedish companies. The business concept is to be an active and long-term stockholder and to further the portfolio companies' development by providing industrial and financial competence at board and management level. The portfolio comprises 9 companies within technology, biotechnology and services. The major holdings are in Bure Equity (17%), MYDATA automation (96%), PartnerTech (36%,and Vitrolife (25%). Skanditek is listed on the OMX Nordic List.
Utilization of authorization within Skanditek to repurchase own shares
| Source: Skanditek Industriförvaltning AB